GlassScriptPhysician profile
Stephen Cowan
NPI 1821059932
$981.41
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $222 · 2021: $133 · 2022: $271 · 2023: $169 · 2024: $72.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $169 · Entertainment: $72.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $168.97 |
| Entertainment | $72.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $334.40 | 2019-2023 | Precision 1 |
| Optos, INC. | $156.74 | 2022-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $100.00 | 2023 | Miebo |
| Ivantis, INC | $77.59 | 2020 | |
| Glaukos Corporation | $61.37 | 2022 | |
| Abbvie INC. | $59.86 | 2022 | |
| Shire North American Group INC | $59.57 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $47.00 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $41.63 | 2019-2020 | |
| Oyster Point Pharma, INC. | $18.14 | 2022 | |
| Novartis Pharmaceuticals Corporation | $13.37 | 2020 | |
| Allergan, INC. | $11.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Cowan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.